Clinical Trials Directory

Trials / Completed

CompletedNCT05531292

PROOF-OF-CONCEPT STUDY FOR NEW INTRAOCULAR LENS, MODEL C0002

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
106 (actual)
Sponsor
Johnson & Johnson Surgical Vision, Inc. · Industry
Sex
All
Age
60 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Prospective, two-arm, randomized, bilateral, subject/evaluator-masked clinical study to evaluate the distance visual acuity, peripheral refractive error and functional vision of the EPV IOL compared to a standard monofocal control IOL.

Conditions

Interventions

TypeNameDescription
DEVICEModel C0002Eligible subjects will be randomized in a 1:1 ratio to the investigational IOL Model C0002 in both eyes for the duration of the study.
DEVICEModel ZCB00/DCB00Eligible subjects will be randomized in a 1:1 ratio to the control IOL Model ZCB00 in both eyes for the duration of the study.

Timeline

Start date
2022-11-22
Primary completion
2025-05-20
Completion
2025-05-20
First posted
2022-09-07
Last updated
2025-07-20

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05531292. Inclusion in this directory is not an endorsement.

PROOF-OF-CONCEPT STUDY FOR NEW INTRAOCULAR LENS, MODEL C0002 (NCT05531292) · Clinical Trials Directory